RENAISSANCE TECHNOLOGIES LLC
Position in ORMP — Oramed Pharmaceuticals Inc.
CIK 1037389
NEW YORK, NY
Position in ORMP
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$502,180
+$81,805 QoQ
Shares Held
147,700
+0.1% QoQ
Ownership
0.361%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,464,545,054 across 328 Biotechnology names. ORMP ranks #225 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in ORMP
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $502,180 | 147,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $420,375 | 147,500 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $393,096 | 148,900 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $324,450 | 144,200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $304,950 | 142,500 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $367,375 | 151,808 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $598,532 | 245,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $593,156 | 230,800 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $356,532 | 122,100 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $787,878 | 341,073 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $115,623 | 44,300 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $120,646 | 33,700 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $25,942 | 11,900 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $1,647,412 | 359,697 | Shares | Sole | 2022-08-12 | |
| 2021-12-31 | $2,901,696 | 203,200 | Shares | Sole | 2022-02-11 | |
| 2020-12-31 | $1,579,039 | 372,415 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,223,085 | 468,615 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $791,831 | 224,315 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $572,781 | 188,415 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||